HK Movers | Biotech Shares Soar. CANbridge up 6%; WuXi XDC up 5%; WuXi Biologics, Ascletis, Hengrui Pharma up 3%
TigerSep 22, 2025 1:58 AM
Hong Kong’s biotech stocks rose on Monday.
CANbridge rose 6%; WuXi XDC rose 5%; WuXi Biologics, Ascletis, Hengrui Pharma rose 3%; CStone Pharmaceuticals rose 1%.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
[Reuters Analysis] China's bull market risks running out of gas: Raychaudhuri
By Manishi Raychaudhuri HONG KONG, Sept 22 (Reuters) - China's onshore equity markets are booming, outperforming many of their developed market counterparts this year. But whether this is the beginning of a true Chinese equity boom or yet another short-lived bubble will likely depend on gover...Reuters
5 hours ago
Investing in Robotics & Automation
Robotics and automation are a structural megatrend driven by labor shortages, supply chain shifts, and the push for efficiency.The investment landscape spans industrial leaders, healthcare innovators, logistics adopters, and semiconductor enablers.TradingKey
Sat, Sep 20
[Reuters Analysis] Why South Korea cannot make the same US trade deal as Japan
South Korea trade talks with U.S. have stalled due to FX issuesCurrency market too small for $350 bln fund, unlike Japan's caseHopes grow that bilateral currency swap line may offer solution By Jihoon Lee and Yena Park SEOUL, Sept 15 (Reuters) - South Korea's negotiations with the U.S. on...Reuters
Tue, Sep 16
Unlocking Gold’s Next Leg: $4,000 in Reach by 2025？
TradingKey - Gold has kicked off a fresh uptrend in early September, breaking out of months of compression and reclaiming key territory. The decisive move above $3,500 establishes a new support base and puts higher objectives back on the table for the weeks aheadTradingKey
Thu, Sep 4
Tradingkey
